
Sign up to save your podcasts
Or


Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
By John Simboli5
77 ratings
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

535 Listeners

3,079 Listeners

1,094 Listeners

938 Listeners

796 Listeners

124 Listeners

324 Listeners

92 Listeners

9,953 Listeners

33 Listeners

498 Listeners

147 Listeners

353 Listeners

171 Listeners

512 Listeners